{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:08:06Z","timestamp":1781024886492,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002994","name":"Ministry of Trade, Industry & Energy","doi-asserted-by":"publisher","award":["10030051"],"award-info":[{"award-number":["10030051"]}],"id":[{"id":"10.13039\/501100002994","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2010-0029220"],"award-info":[{"award-number":["2010-0029220"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013M3A9D3045879"],"award-info":[{"award-number":["2013M3A9D3045879"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013K1A1A2A02050188"],"award-info":[{"award-number":["2013K1A1A2A02050188"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007603","name":"Korea Food and Drug Administration","doi-asserted-by":"crossref","award":["KFDA-13172-306"],"award-info":[{"award-number":["KFDA-13172-306"]}],"id":[{"id":"10.13039\/501100007603","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013R1A1A2012483"],"award-info":[{"award-number":["2013R1A1A2012483"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health, USA","doi-asserted-by":"crossref","award":["CA 107070"],"award-info":[{"award-number":["CA 107070"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.biomaterials.2014.11.021","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T20:03:42Z","timestamp":1417723422000},"page":"53-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus"],"prefix":"10.1016","volume":"41","author":[{"given":"Chang Yoon","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung-Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayananda","family":"Kasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2014.11.021_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/cgt.2012.95","article-title":"Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers","volume":"20","author":"Choi","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1517\/17425240802507636","article-title":"Cancer gene therapy with targeted adenoviruses","volume":"5","author":"Bachtarzi","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib5","first-page":"356","article-title":"Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy","volume":"10","author":"Yun","year":"2008","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib6","first-page":"217","article-title":"Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses","volume":"1785","author":"Guo","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.addr.2006.05.005","article-title":"Recombinant viral vectors: cancer vaccines","volume":"58","author":"Harrop","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.gt.3301512","article-title":"Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial","volume":"8","author":"Reid","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib10","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/1078-0432.CCR-10-0664","article-title":"A\u00a0hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas","volume":"16","author":"Kwon","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr Cancer Drug Target"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<360::AID-JGM54>3.0.CO;2-Q","article-title":"Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits","volume":"1","author":"Cichon","year":"1999","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jgm.409","article-title":"Adenovirus endocytosis","volume":"5","author":"Meier","year":"2003","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib14","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2011.11.020","article-title":"Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/17425247.5.4.385","article-title":"Polymers for viral gene delivery","volume":"5","author":"Wang","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5483\/BMBRep.2010.43.12.781","article-title":"Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity","volume":"43","author":"Kang","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"Kasala","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.2011.10439.x","article-title":"Adenovirus-relaxin gene therapy for keloids: implication for reversing pathological fibrosis","volume":"165","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib19","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.biomaterials.2013.03.004","article-title":"Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2007.08.025","article-title":"Development of PEGylated adenovirus vector with targeting ligand","volume":"354","author":"Eto","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib21","doi-asserted-by":"crossref","first-page":"105106","DOI":"10.1088\/0957-4484\/21\/10\/105106","article-title":"Combination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transduction","volume":"21","author":"Han","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2009.11.001","article-title":"Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction","volume":"142","author":"Park","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In\u00a0vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2008.05.003","article-title":"Recent progress in tumor pH targeting nanotechnology","volume":"132","author":"Lee","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib25","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.mt.6300023","article-title":"VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth","volume":"15","author":"Yoo","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2007.07.012","article-title":"Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy","volume":"123","author":"Ko","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib28","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1016\/j.biomaterials.2012.05.025","article-title":"Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2010.06.027","article-title":"Ionically crosslinked Ad\/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy","volume":"148","author":"Park","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib30","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"Wang","year":"1993","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1006\/excr.1999.4652","article-title":"Tyrosine phosphorylation of caveolin-1 in the endothelium","volume":"253","author":"Aoki","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib33","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.biomaterials.2008.04.038","article-title":"The effect of surface functionality on cellular trafficking of dendrimers","volume":"29","author":"Perumal","year":"2008","journal-title":"Biomaterials"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.biomaterials.2014.11.021_bib34","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/jgm.553","article-title":"Adenovirus endocytosis","volume":"6","author":"Meier","year":"2004","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib35","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in\u00a0vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib37","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/jvi.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors","volume":"71","author":"Lieber","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib38","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in\u00a0vitro and in\u00a0vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/10611860701501014","article-title":"Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy","volume":"15","author":"Fisher","year":"2007","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.gt.3301389","article-title":"Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies","volume":"8","author":"Fisher","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2011.06.014","article-title":"Viral genome DNA\/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery","volume":"155","author":"Kwon","year":"2011","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib43","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/bm300665u","article-title":"Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy","volume":"13","author":"Yao","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/mt.2011.112","article-title":"Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy","volume":"19","author":"Yao","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib45","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.biomaterials.2011.03.084","article-title":"Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/hum.2008.167","article-title":"Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer","volume":"20","author":"Morrison","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib47","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2967\/jnumed.109.068981","article-title":"Tumor pH and its measurement","volume":"51","author":"Zhang","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib48","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.11.021_bib49","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","article-title":"\u201cStealth\u201d adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung","volume":"75","author":"Croyle","year":"2001","journal-title":"J\u00a0Virol"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214011818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214011818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:04:57Z","timestamp":1758902697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961214011818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":49,"alternative-id":["S0142961214011818"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.11.021","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}